Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models.

Cox RM, Lieber CM, Wolf JD, Karimi A, Lieberman NAP, Sticher ZM, Roychoudhury P, Andrews MK, Krueger RE, Natchus MG, Painter GR, Kolykhalov AA, Greninger AL, Plemper RK

Open source

DOI
10.1038/s41467-023-40556-8
Published
2023 Aug 7
Container
Nature communications
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41467-023-40556-8,
  title = {Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models.},
  author = {Cox RM and Lieber CM and Wolf JD and Karimi A and Lieberman NAP and Sticher ZM and Roychoudhury P and Andrews MK and Krueger RE and Natchus MG and Painter GR and Kolykhalov AA and Greninger AL and Plemper RK},
  year = {2023},
  journal = {Nature communications},
  doi = {10.1038/s41467-023-40556-8},
  url = {https://doi.org/10.1038/s41467-023-40556-8}
}

RIS

TY  - JOUR
TI  - Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models.
AU  - Cox RM
AU  - Lieber CM
AU  - Wolf JD
AU  - Karimi A
AU  - Lieberman NAP
AU  - Sticher ZM
AU  - Roychoudhury P
AU  - Andrews MK
AU  - Krueger RE
AU  - Natchus MG
AU  - Painter GR
AU  - Kolykhalov AA
AU  - Greninger AL
AU  - Plemper RK
PY  - 2023
JO  - Nature communications
DO  - 10.1038/s41467-023-40556-8
UR  - https://doi.org/10.1038/s41467-023-40556-8
ER  - 

APA

RM, C., CM, L., JD, W., A, K., NAP, L., ZM, S., P, R., MK, A., RE, K., MG, N., GR, P., AA, K., AL, G., & RK, P. (2023). Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models.. Nature communications. https://doi.org/10.1038/s41467-023-40556-8

Source records